Xarelto® & Pradaxa®

Recently, dangerous side effects relating to the use of Xarelto® has come to light. These include: internal bleeding, brain hemorrhaging, kidney bleeding, and death. In order to protect yourself and get the compensation you need to recover, our team can fight for you throughout every stage of the process.

Xarelto® is a drug given to patients with irregular heartbeats to reduce the risk of stroke and blood clots.  Unfortunately Xarelto® and Pradaxa® have now been associated with serious internal bleeding; so serious that deaths have resulted after taking these drugs.  If you or a loved one has taken Xarelto® and suffered from a serious bleeding event, stroke, or hemorrhage or please call Goldberg Attorneys today, (800) 600-6014.

Recently, dangerous side effects relating to the use of Xarelto® has come to light. These include: internal bleeding, brain hemorrhaging, kidney bleeding, and death. In order to protect yourself and get the compensation you need to recover, our team can fight for you throughout every stage of the process.

Xarelto® is a drug given to patients with irregular heartbeats to reduce the risk of stroke and blood clots.  Unfortunately Xarelto® and Pradaxa® have now been associated with serious internal bleeding; so serious that deaths have resulted after taking these drugs.  If you or a loved one has taken Xarelto® and suffered from a serious bleeding event, stroke, or hemorrhage or please call Goldberg Attorneys today, (800) 600-6014.

Goldberg Attorneys are investigating Xarelto®.

Harmful side effects, including:

  • Brain hemorrhaging
  • Internal bleeding
  • Gastrointestinal (GI) bleeding
  • Kidney bleeding
  • Death from “bleeding out”

These are serious conditions and, if a drug you took did cause one of these conditions, Goldberg Attorneys feels you should be compensated.  Please call 800-600-6014 to find out if you have a case.

Call Goldberg Attorneys today for help

or fill out the contact form below.

or fill out the contact form below.

For more extensive information, please visit:

Forbes: FDA Plans New Safety Assessment Of Dabigatran (Pradaxa)